Ken Cacciatore
Stock Analyst at TD Cowen
(0.23)
# 3,597
Out of 4,667 analysts
14
Total ratings
27.27%
Success rate
-28.39%
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $10.18 | +391.16% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $8.19 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical | Maintains: Outperform | $30 → $20 | $13.29 | +50.49% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $3.36 | +644.05% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $19.38 | +80.60% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $5.20 | +861.56% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $2.31 | +2,064.50% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $46.83 | -3.91% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $23 | $0.49 | +4,552.10% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $25 | $0.37 | +6,711.99% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $10.18
Upside: +391.16%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $8.19
Upside: -
Takeda Pharmaceutical
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $13.29
Upside: +50.49%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $3.36
Upside: +644.05%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $19.38
Upside: +80.60%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $5.20
Upside: +861.56%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $2.31
Upside: +2,064.50%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $46.83
Upside: -3.91%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $23
Current: $0.49
Upside: +4,552.10%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $25
Current: $0.37
Upside: +6,711.99%